FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037745707> ?p ?o ?g. }

• W3037745707 abstract "Abstract Background Reliable assessment of remission is important for the optimal management of rheumatoid arthritis (RA) patients. In this study, we used the multi-biomarker disease activity (MBDA) test to explore the role of biomarkers in predicting point remission and sustained remission. Methods RA patients on > 6 months stable therapy in stable low disease activity (DAS28-ESR ≤ 3.2) were assessed every 3 months for 1 year. Baseline, intermittent (IR) and sustained (SR) remission were defined by DAS28-ESR, DAS28-CRP, simple disease activity index (SDAI), clinical disease activity index (CDAI) and ACR/EULAR Boolean criteria. Patients not fulfilling any remission criteria at baseline were classified as ‘low disease activity state’ (LDAS). Patients not fulfilling any remission criteria over 1 year were classified as ‘persistent disease activity’ (PDA). MBDA score was measured at baseline/3/6 months. The baseline MBDA score, the 6-month time-integrated MBDA score and MBDA biomarkers were used for analyses. The area under the receiver operating characteristic curve (AUROC) assessed the ability of the MBDA score to discriminate between remission and non-remission. Biomarkers were analysed at baseline using the Mann-Whitney test and over time using the Jonckheere-Terpstra trend test. Results Of 148 patients, 27% were in the LDAS, 65% DAS28-ESR remission, 51% DAS28-CRP remission, 40% SDAI remission, 43% CDAI remission and 25% ACR/EULAR Boolean remission at baseline. Over 1 year, 9% of patients were classified as PDA. IR and SR were achieved in 42%/47% by DAS28-ESR, 46%/29% by DAS28-CRP, 45%/20% by SDAI, 44%/21% by CDAI and 35%/9% by ACR/EULAR Boolean criteria, respectively. By all remission criteria, baseline MBDA score discriminated baseline remission (AUROCs 0.68–0.75) and IR/SR (AUROCs 0.65–0.74). The 6-month time-integrated MBDA score discriminated IR/SR (AUROCs 0.65–0.79). Baseline MBDA score and concentrations of IL-6, leptin, SAA and CRP were significantly lower in all baseline remission criteria groups vs LDAS. They and the 6-month time-integrated values were lower among patients who achieved IR/SR vs PDA over 1 year. Conclusions This study demonstrated that the MBDA score and its biomarkers IL-6, leptin, SAA and CRP differentiated between small differences in disease activity (i.e. between low disease activity and remission states). They were also predictors of remission over 1 year." @default.
• W3037745707 created "2020-07-02" @default.
• W3037745707 creator A5001941855 @default.
• W3037745707 creator A5002092452 @default.
• W3037745707 creator A5012639509 @default.
• W3037745707 creator A5024895476 @default.
• W3037745707 creator A5040915422 @default.
• W3037745707 creator A5046800079 @default.
• W3037745707 creator A5050928134 @default.
• W3037745707 date "2020-06-24" @default.
• W3037745707 modified "2023-10-16" @default.
• W3037745707 title "A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis" @default.
• W3037745707 cites W1588610010 @default.
• W3037745707 cites W1810470786 @default.
• W3037745707 cites W1964095605 @default.
• W3037745707 cites W2000832741 @default.
• W3037745707 cites W2019159305 @default.
• W3037745707 cites W2035851586 @default.
• W3037745707 cites W2063236332 @default.
• W3037745707 cites W2076170818 @default.
• W3037745707 cites W2095625290 @default.
• W3037745707 cites W2098279921 @default.
• W3037745707 cites W2099334955 @default.
• W3037745707 cites W2116337450 @default.
• W3037745707 cites W2135843902 @default.
• W3037745707 cites W2137251251 @default.
• W3037745707 cites W2140410277 @default.
• W3037745707 cites W2141624058 @default.
• W3037745707 cites W2147798113 @default.
• W3037745707 cites W2148357532 @default.
• W3037745707 cites W2153847683 @default.
• W3037745707 cites W2158733279 @default.
• W3037745707 cites W2172011800 @default.
• W3037745707 cites W2204687884 @default.
• W3037745707 cites W2279670802 @default.
• W3037745707 cites W2590722608 @default.
• W3037745707 cites W2804970071 @default.
• W3037745707 cites W2859548373 @default.
• W3037745707 cites W2889130652 @default.
• W3037745707 cites W2897837561 @default.
• W3037745707 cites W2906042285 @default.
• W3037745707 cites W2952559911 @default.
• W3037745707 cites W4249063051 @default.
• W3037745707 doi "https://doi.org/10.1186/s13075-020-02240-w" @default.
• W3037745707 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7313155" @default.
• W3037745707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32580789" @default.
• W3037745707 hasPublicationYear "2020" @default.
• W3037745707 type Work @default.
• W3037745707 sameAs 3037745707 @default.
• W3037745707 citedByCount "20" @default.
• W3037745707 countsByYear W30377457072020 @default.
• W3037745707 countsByYear W30377457072021 @default.
• W3037745707 countsByYear W30377457072022 @default.
• W3037745707 countsByYear W30377457072023 @default.
• W3037745707 crossrefType "journal-article" @default.
• W3037745707 hasAuthorship W3037745707A5001941855 @default.
• W3037745707 hasAuthorship W3037745707A5002092452 @default.
• W3037745707 hasAuthorship W3037745707A5012639509 @default.
• W3037745707 hasAuthorship W3037745707A5024895476 @default.
• W3037745707 hasAuthorship W3037745707A5040915422 @default.
• W3037745707 hasAuthorship W3037745707A5046800079 @default.
• W3037745707 hasAuthorship W3037745707A5050928134 @default.
• W3037745707 hasBestOaLocation W30377457071 @default.
• W3037745707 hasConcept C126322002 @default.
• W3037745707 hasConcept C12868164 @default.
• W3037745707 hasConcept C185592680 @default.
• W3037745707 hasConcept C1862650 @default.
• W3037745707 hasConcept C198451711 @default.
• W3037745707 hasConcept C2777575956 @default.
• W3037745707 hasConcept C2781197716 @default.
• W3037745707 hasConcept C55493867 @default.
• W3037745707 hasConcept C58471807 @default.
• W3037745707 hasConcept C71924100 @default.
• W3037745707 hasConceptScore W3037745707C126322002 @default.
• W3037745707 hasConceptScore W3037745707C12868164 @default.
• W3037745707 hasConceptScore W3037745707C185592680 @default.
• W3037745707 hasConceptScore W3037745707C1862650 @default.
• W3037745707 hasConceptScore W3037745707C198451711 @default.
• W3037745707 hasConceptScore W3037745707C2777575956 @default.
• W3037745707 hasConceptScore W3037745707C2781197716 @default.
• W3037745707 hasConceptScore W3037745707C55493867 @default.
• W3037745707 hasConceptScore W3037745707C58471807 @default.
• W3037745707 hasConceptScore W3037745707C71924100 @default.
• W3037745707 hasFunder F4320319990 @default.
• W3037745707 hasIssue "1" @default.
• W3037745707 hasLocation W30377457071 @default.
• W3037745707 hasLocation W30377457072 @default.
• W3037745707 hasLocation W30377457073 @default.
• W3037745707 hasOpenAccess W3037745707 @default.
• W3037745707 hasPrimaryLocation W30377457071 @default.
• W3037745707 hasRelatedWork W1975151676 @default.
• W3037745707 hasRelatedWork W1998237860 @default.
• W3037745707 hasRelatedWork W2007691328 @default.
• W3037745707 hasRelatedWork W2007849701 @default.
• W3037745707 hasRelatedWork W2056486996 @default.
• W3037745707 hasRelatedWork W2410978906 @default.
• W3037745707 hasRelatedWork W2568698376 @default.
• W3037745707 hasRelatedWork W2982537455 @default.
• W3037745707 hasRelatedWork W3020467361 @default.
• W3037745707 hasRelatedWork W3079246402 @default.

• next